Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer

NCT00148681 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT00148681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00148681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Lead sponsor
Dana-Farber Cancer Institute
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2001
Completion date
May 31, 2003
Enrollment
49 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, stage ii breast cancer, stage iii breast cancer